Goodwin, Covington Lead Braveheart Bio's $383M IPO
By Jade Martinez-Pogue · August 6, 2026, 5:00 PM EDT
Venture-backed biotechnology firm Braveheart Bio hit the public markets on Thursday after raising $383 million in its upsized initial public offering....
To view the full article, register now.